Hemokinin is a Hematopoietic-Specific Tachykinin That Regulates B Lymphopoiesis

Yu Zhang,Liwei Lu,Caren Furlonger,Gillian E. Wu,Christopher J. Paige

DOI: https://doi.org/10.1038/80826

IF: 30.5

2000-01-01

Nature Immunology

Abstract:We report here the molecular cloning of a newly identified preprotachykinin gene, Pptc , which specifies the sequence for a new preprotachykinin protein and bioactive peptide designated hemokinin 1 (HK-1). PPT-C mRNA was detected primarily in hematopoietic cells in contrast to the previously described Ppta and Pptb genes, which are predominantly expressed in neuronal tissues. HK-1 has several biological activities that are similar to the most studied tachykinin, substance P, such as induction of plasma extravasation and mast cell degranulation. However, HK-1 also has properties that are indicative of a critical role in mouse B cell development. HK-1 stimulated the proliferation of interleukin 7–expanded B cell precursors, whereas substance P had no effect. HK-1, but not substance P, promoted the survival of freshly isolated bone marrow B lineage cells or cultured, lipopolysaccharide-stimulated pre-B cells. N -acetyl- l -trytophan-3,5-bistrifluromethyl benzyl ester, a tachykinin receptor antagonist, increased apoptosis of these cells and in vivo administration of this antagonist led to specific reductions of the B220 low CD43 − population (the pre-B cell compartment) in the bone marrow and the IgM high IgD low population (the newly generated B cells) in the spleen. Thus, HK-1 may be an autocrine factor that is important for the survival of B cell precursors at a critical phase of development.